UTI Portfolio Companies
IGNITE actively manages the University of Calgary's interest in these companies.
- AB Biopharma Inc. 2002 - AB Biopharma Inc. is a biopharmaceutical company developing oral growth factor-based formulations for several pediatric gastro-intestinal indications.
- Oncolytics Biotech Inc. 1999 - (ONC.TSX) Oncolytics Biotech Inc. is involved in the development of its proprietary product, REOLYSIN®*, as a potential therapeutic for a wide variety of human cancers.
- AIM Therapeutics Inc. 1998 - (formerly SalPep Biotechnology Inc.) - AIM Therapeutics is an early stage biopharmaceutical company developing anti-inflammatory peptides in various acute and chronic inflammatory diseases such as asthma, spinal cord injuries and atopic dermatitis.
- Innovotech 1996 - (IOT.V) (formerly MBEC Biofilm Ltd.)- Innovotech is a product development company utilizing its core expertise in micorbial biofilms to resolve client biofilm issues.
- SemBioSys Genetics Inc. 1995 - Genetics Inc. (SBS.TSX) is a biotechnology company engaged in the development and commercialization of protein pharmaceutical and non-pharmaceutical products.
- Membrane Reactor Technolgies Inc. 1994 - 1994 is developing a fluidized bed membrane reactor for the production of hydrogen for fuel cells and other applications.
- NeuroSpheres Ltd. & NeuroSpheres Holdings Ltd. 1992 - The founding company was developed to pursue research and development in the area of neural stem cell regeneration and differentiation at the University of Calgary Medical Faculty. NeuroSpheres Ltd. now monitors a significant portfolio of licenses and actively seeks further commercialization of its patented technologies.
